News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Torres S. Edward
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/23/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
3
| LV Management Group, LLC (10% Owner) has filed a Form 3 on Surface Oncology, Inc. |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/16/2016 |
4
| LV Management Group, LLC (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc |
| 08/10/2016 |
3
| LV Management Group, LLC (10% Owner) has filed a Form 3 on Protagonist Therapeutics, Inc |
| 04/06/2016 |
3
| Lilly Ventures Fund I LLC (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 03/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/19/2013 |
4
| Torres S. Edward (Director) has filed a Form 4 on Receptos, Inc.|
Txns:
| Granted 18,800 options to buy
@ $18.77, valued at
$352.9k
|
|
| 05/08/2013 |
3
| Torres S. Edward (Director) has filed a Form 3 on Receptos, Inc. |
|
|